In this first-of-its-kind partnership for its Dental Solutions business, Solventum, formerly 3M Health Care, is striving to focus on longevity and durability of permanent same-day restorative dental offerings, reaffirming its commitment to solving industry's toughest problems Partnership aims to integrate innovative new material science and disruptive technology like chairside 3D printing to optimize workflows, enhance... Read More

Provides 2028 Targets for Revenue Growth, Margin Expansion, and Free Cash Flow ST. PAUL, Minn. , March 20, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today hosts its 2025 Investor Day and will outline strategic priorities for the Company, its business segments, and its long-range plan (LRP) to drive growth and value creation. "Solventum has tremendous potential, with attractive businesses, large and growing markets, and... Read More

ST. PAUL, Minn. , March 12, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today announced the launch of the Attest™ eBowie-Dick Test System (eBowie-Dick System), an electronic test card and auto-reader for sterilization testing that eliminates the need for visual interpretation of results and manual... Read More

Reported sales increased 1.9% to $2.074 billion ; organic sales increased 2.3% GAAP diluted Earnings Per Share (EPS) of $0.17 ; adjusted EPS 1 of $1.41 Generated $219 million in cash from operations; free cash flow of $92 million Introduces full-year 2025 organic sales growth, adjusted EPS and free cash flow guidance ST. PAUL, Minn. , Feb. 27, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for... Read More

Learn more about Solventum's long-term strategy to accelerate growth Join in person or via virtual webcast ST. PAUL, Minn. , Feb. 26, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) will host an investor day on Thursday, March 20, 2025 , beginning at approximately 1:00 p.m. Eastern Standard Time . The event will be held in New York City and simultaneously webcast online. More information about this event, including registration... Read More

Accelerates Solventum's business transformation and sharpens focus on strategic areas for growth to deliver long-term shareholder value Strengthens balance sheet with proceeds to be used primarily for debt paydown ST. PAUL, Minn. , Feb. 25, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today announced it has entered into a definitive agreement to sell its Purification & Filtration 1 business to Thermo Fisher Scientific Inc.... Read More

BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Ampersand Biomedicines, a multi-product platform company developing smarter medicines that act specifically at the site of disease and nowhere else, today announced the appointment of Elizabeth Mily to its Board of Directors as Independent Director. A highly respected healthcare and financial industry veteran with more than 30 years of experience, Mily brings extensive expertise in... Read More

ST. PAUL, Minn. , Feb. 5, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) Solventum today announced that its AI-powered radiology speech reporting solution, Solventum™ Fluency™ for Imaging, has ranked #1 in the 2025 Best in KLAS Awards—Software and Services Report for the fifth time. Enabling faster, more accurate documentation, Solventum Fluency for Imaging helps radiologists save time, reduce burnout and improve efficiency by... Read More

Company to host an Investor Day in March 2025 ST. PAUL, Minn. , Jan. 30, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its fourth quarter fiscal year 2024 financial results on Thursday, February 27, 2025 , after the U.S. financial markets close. Following the release, Solventum management will host a webcast to discuss the results and fiscal year 2025 outlook. Other forward-looking and material information may... Read More

Despite Performance Declines Since Spinning Out of 3M, Trian Believes Solventum Has Potential to Drive Significant Improvements as a Standalone Company If Solventum Can Restore Performance to Historical Levels, Trian Believes the Company’s Shares Could be Worth $140 by Year-End 2027 vs. its $69 Share Price Today Trian Believes the Company Can Further Enhance Value Creation Through Improved Operating Performance, Portfolio... Read More

Former Bristol Myers Squibb, Goldman Sachs, and Barclays executive brings deep expertise in corporate strategy, partnership development, public and private financial markets, and management as the organization evolves its leadership and investment strategy Appointment signals plans to capitalize on previous success and... Read More

ST. PAUL, Minn. , Nov. 19, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that its executives will participate in a fireside chat at the Piper Sandler 36 th Annual Healthcare Conference on Wednesday, December 4, 2024 at 11:30 a.m. ET in New York, NY . A live and archived replay of the fireside chat will be available on the company's website at investors.solventum.com . About Solventum At Solventum, we enable... Read More

Clarity Precision Grip Attachments are fully cured, pre-loaded and precisely resemble the digital treatment plan after bonding ST. PAUL, Minn. , Nov. 14, 2024 /PRNewswire/ -- This month, Solventum (NYSE: SOLV), formerly 3M Health Care, officially launched an anticipated innovation in aligner treatment, 3M™ Clarity™ Precision Grip Attachments . Available exclusively with 3M™ Clarity™ Aligners, Clarity Precision Grip... Read More

Reported sales increased 0.4% to $2.082 billion ; organic sales increased 0.3% GAAP Earnings Per Share (EPS) of $0.70 ; adjusted EPS 1 of $1.64 Generated $169 million in cash from operations; free cash flow 1 of $76 million Raises full-year 2024 organic sales growth, adjusted EPS and free cash flow guidance ST. PAUL, Minn. , Nov. 7, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the third... Read More